%0 Journal Article
%T Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
%A Bin Qu
%A Feng Gu
%A Hua Fang
%A Jun Meng
%J Journal of Cancer
%D 2019
%I Ivyspring International Publisher
%R 10.7150/jca.28409
%X Background: Previous studies suggest S100A9 is a promising biomarker for prognosis in cancer, including hepatocellular carcinoma (HCC). We examined the utility of serum S100A9 in predicting prognosis in HCC after curative resection.
%K hepatocellular carcinoma
%K serum biomarker
%K S100A9
%K prognosis
%K curative resection
%U http://www.jcancer.org/v10p0408.htm